Scientists probe how SMA drug affects nerve signals
NCT ID NCT05219487
Summary
This study aimed to understand how the approved drug Risdiplam affects the connection between nerves and muscles in adults with Spinal Muscular Atrophy (SMA). It observed 18 adults who had already been taking the daily oral medication for at least one year. Researchers performed a single visit with various tests to measure nerve signal strength, muscle function, and fatigue to learn more about how the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.